Hallucinogens: Clinical Trials

4 trials of Hallucinogens, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 completed, 1 recruiting, 1 unknown. 2 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Active not recruiting 1, Completed 1
Phase 21Recruiting 1

Follow Hallucinogens: new trials by email Literature Review of Hallucinogens trials Research Report on Hallucinogens

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Preliminary Efficacy of Organic Whole Psilocybin-Containing Mushrooms to Treat Patients Suffering From PTSD
Psychedelic - PTSD
Phase 1Active not recruitingScottsdale Research Institute242026-03-202026-07-29
Pragmatic Trial of Psilocybin Therapy in Palliative Care
Psilocybin, Ketamine - Demoralization
Phase 2RecruitingCharles S. Grob, M.D.1002025-01-192025-11-25
Psychedelic Therapy for Wellness Studies Retrospectively
Psychedelic - Well Aging
UnknownCanadian Forces Health Services Centre Ottawa1002022-07-192023-08-30
Effects of Hallucinogens and Other Drugs on Mood and Performance
Hallucinogens and psychoactive substances - Healthy
Phase 1CompletedJohns Hopkins University202014-04-012019-05-16

Conditions studied

Stress Disorders, Post-Traumatic (1)

Sponsors

Canadian Forces Health Services Centre Ottawa (1)  ·  Charles S. Grob, M.D. (1)  ·  Johns Hopkins University (1)  ·  Scottsdale Research Institute (1)

Countries

United States (3)  ·  Canada (1)

Top investigators

Charles S. Grob, M.D. (1)  ·  Gaurav Gupta (1)  ·  Roland R Griffiths, Ph.D. (1)

Results publications

PMID 38152462, PMID 39260823